Working towards a common goal – the eradication of cancer
As one of the leading causes of death worldwide, cancers are an incredibly complex array of disease states, resulting largely from a series of mutations that enable cells to multiply and resist the body’s defences against unchecked cell proliferation. Despite such extensive heterogeneity, distinct molecular signatures can drive cancer progression and help to predict treatment response.
Understanding the genomic and transcriptomic changes that occur in cancer cells is key to developing potential therapeutics. Our team has the experience and expertise to support your cancer research efforts with a suite of state-of-the-art next-generation sequencing platforms. In addition, we can help you design and optimize your cancer research studies, as well as analyze and interpret your data for greater biological insight.
Because we understand that you face many challenges in your research, our Genomics and Bioinformatics services are fully customizable to ensure you can efficiently and rapidly reach your cancer research and development goals.
Additional areas of human health expertise: